Last Updated on June 22, 2023

Pharmacogenomics and Personalized Medicine- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Dove Medical Press Ltd.

Abbreviation: Pharmacogenomics Pers. Med.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

1.87

SJR

 0.469

h-Index

 34

Rank

 10938

Important Details

Title Pharmacogenomics and Personalized Medicine
Standard Abbreviation Pharmacogenomics Pers. Med.
Type of Publication Journal
Discipline Molecular Medicine (Q3); Pharmacology (Q3)
Impact Score 1.87
SCImago Journal Rank (SJR) 0.469
h-index 34
Overall Rank 10938
Publisher Name Dove Medical Press Ltd.
Publication Country New Zealand
International Standard Serial Number (ISSN) 11787066
Coverage and History 2009-2022
Best Quartile Q3
Total Citations Received
(Last 3 Year)
538

About Pharmacogenomics and Personalized Medicine


Pharmacogenomics and Personalized Medicine is a journal published by Dove Medical Press Ltd.. This journal covers the area[s] related to Molecular Medicine, Pharmacology, etc. The coverage history of this journal is as follows: 2009-2022. The rank of this journal is 10938. This journal's impact score, h-index, and SJR are 1.87, 34, and 0.469, respectively. The ISSN of this journal is/are as follows: 11787066.

The best quartile of Pharmacogenomics and Personalized Medicine is Q3. This journal has received a total of 538 citations during the last three years (Preceding 2022).


Pharmacogenomics and Personalized Medicine Impact Score 2022-2023


The latest impact score (IS) of the Pharmacogenomics and Personalized Medicine is 1.87. It is computed in the year 2023 as per its definition and based on Scopus data. 1.87

It is decreased by a factor of around 0.73, and the percentage change is -28.08% compared to the preceding year 2021, indicating a falling trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Pharmacogenomics and Personalized Medicine Impact Score 2023


Impact Score 2022 of Pharmacogenomics and Personalized Medicine is 1.87. If a similar downward trend continues, IS may decrease in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Pharmacogenomics and Personalized Medicine. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.87
2021 2.60
2020 3.96
2019 3.72
2018 3.20
2017 3.93
2016 4.75
2015 4.46
2014 3.41

Pharmacogenomics and Personalized Medicine h-index


  Table Setting

The h-index of Pharmacogenomics and Personalized Medicine is 34. By definition of the h-index, this journal has at least 34 published articles with more than 34 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Pharmacogenomics and Personalized Medicine ISSN


The International Standard Serial Number (ISSN) of Pharmacogenomics and Personalized Medicine is/are as follows: 11787066.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Pharmacogenomics and Personalized Medicine Ranking and SCImago Journal Rank (SJR)


The Pharmacogenomics and Personalized Medicine is ranked 10938 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 0.469.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Pharmacogenomics and Personalized Medicine Publisher


Table Setting

The publisher of Pharmacogenomics and Personalized Medicine is Dove Medical Press Ltd.. The publishing house of this journal is located in the New Zealand. Its coverage history is as follows: 2009-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Pharmacogenomics and Personalized Medicine is Pharmacogenomics Pers. Med.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Pharmacogenomics Pers. Med.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Pharmacogenomics and Personalized Medicine


If your area of research or discipline is related to Molecular Medicine, Pharmacology, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Pharmacogenomics and Personalized Medicine?

The latest impact score of Pharmacogenomics and Personalized Medicine is 1.87. It is computed in the year 2023.


What is the h-index of Pharmacogenomics and Personalized Medicine?

The latest h-index of Pharmacogenomics and Personalized Medicine is 34. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Pharmacogenomics and Personalized Medicine?

The latest SCImago Journal Rank (SJR) of Pharmacogenomics and Personalized Medicine is 0.469. It is calculated in the year 2023.


What is the ranking of Pharmacogenomics and Personalized Medicine?

The latest ranking of Pharmacogenomics and Personalized Medicine is 10938. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Pharmacogenomics and Personalized Medicine?

Pharmacogenomics and Personalized Medicine is published by Dove Medical Press Ltd.. The publication country of this journal is New Zealand.


What is the abbreviation of Pharmacogenomics and Personalized Medicine?

This standard abbreviation of Pharmacogenomics and Personalized Medicine is Pharmacogenomics Pers. Med..


Is "Pharmacogenomics and Personalized Medicine" a Journal, Conference or Book Series?

Pharmacogenomics and Personalized Medicine is a journal published by Dove Medical Press Ltd..


What is the scope of Pharmacogenomics and Personalized Medicine?

The scope of Pharmacogenomics and Personalized Medicine is as follows:

  • Molecular Medicine
  • Pharmacology

For detailed scope of Pharmacogenomics and Personalized Medicine, check the official website of this journal.


What is the ISSN of Pharmacogenomics and Personalized Medicine?

The International Standard Serial Number (ISSN) of Pharmacogenomics and Personalized Medicine is/are as follows: 11787066.


What is the best quartile for Pharmacogenomics and Personalized Medicine?

The best quartile for Pharmacogenomics and Personalized Medicine is Q3.


What is the coverage history of Pharmacogenomics and Personalized Medicine?

The coverage history of Pharmacogenomics and Personalized Medicine is as follows 2009-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Business: Theory and Practice Journal Vilnius Gediminas Technical University 13414 21 2.47
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
SPE Production and Operations Symposium, Proceedings Conference And Proceedings 15907 21 0.00
Current Sociology Journal SAGE Publications Ltd 6591 76 2.29
International Journal of Mathematical Education in Science and Technology Journal Taylor and Francis Ltd. 10040 39 1.33
Archives of Phytopathology and Plant Protection Journal Taylor and Francis Ltd. 14852 29 1.14
World Englishes Journal Wiley-Blackwell 4960 60 1.97
Natural Solutions Trade Journal Innovision Health Media 28581 1 0.00
Population Review Journal Sociological Demography Press 17841 13 0.73
Proceedings of the Technical Association of the Graphic Arts, TAGA Conference And Proceedings Technical Association of the Graphic 30903 8 0.00

Check complete list




Pharmacogenomics and Personalized Medicine Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 1.87
2021 2.60
2020 3.96
2019 3.72
2018 3.20
2017 3.93
2016 4.75
2015 4.46
2014 3.41



Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd. | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Biomarker Research
BioMed Central Ltd. | United Kingdom

Cellular and Molecular Life Sciences
Birkhauser Verlag Basel | Switzerland

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Inc. | United States

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

Acta Pharmaceutica Sinica B
Elsevier BV | Netherlands

See All